Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Digoxin In Treatment of Alcohol Associated Hepatitis (DIGIT-AlcHep)

NCT05014087 is registered in ClinicalTrials.gov with Yale University as lead sponsor.

NCT NCT05014087
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05014087 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Digoxin In Treatment of Alcohol Associated Hepatitis (DIGIT-AlcHep)
Lead sponsor
Yale University
Phase
Phase 2
Overall status
Terminated
Start date
October 8, 2021
Completion date
September 12, 2025
Enrollment
23 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute alcoholic hepatitis, alcohol-induced disorders, chemical and drug induced liver injury, steatohepatitis caused by ingestible alcohol